Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
02/2003
02/12/2003EP0669920B1 Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds
02/12/2003CN1397148A Luminescent element material and luminescent element comprising the same
02/12/2003CN1396920A 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
02/12/2003CN1396163A Thiophen sulfuryl compound
02/12/2003CN1101394C Sulfonyloxadiazolones and their use as mirobicides
02/12/2003CN1101392C Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quindinone derivatives
02/12/2003CN1101384C Process for preparing 1-biphenylmethylmidazole derivatives
02/11/2003US6518433 Process for the preparation of nitroguanidine derivatives
02/11/2003US6518429 Anticancer agents, treating restenosis, atherosclerosis and hepatitis virus
02/11/2003US6518427 Compounds are exceedingly water soluble which is useful in preparing pharmaceutical formulations of these compounds. They are also rapidly converted back to the parent amines in vivo, making them useful as prodrugs of the parent amines.
02/11/2003US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
02/11/2003US6518292 Heterocyclic aromatic compounds usefuls as growth hormone secretagogues
02/11/2003US6518291 Inosine-5'-monophosphate dehydrogenase inhibitors
02/11/2003US6518289 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
02/11/2003US6518286 Compounds
02/11/2003US6518285 Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials
02/11/2003US6518279 Cyclopentanone dihydropyridine compounds useful as potassium channel openers
02/11/2003US6518267 Protease inhibitors
02/11/2003US6518266 1- Aryl-3-thioalkyl pyrazoles, the synthesis thereof and the use thereof as insecticides
02/11/2003CA2047237C Chroman derivatives
02/11/2003CA2022691C 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
02/10/2003WO2002012229A1 Heterocyclylalkyl azole derivatives and use thereof as pesticidal agents
02/10/2003CA2418945A1 Heterocyclylalkylazole derivatives and their use as pesticides
02/09/2003CA2397150A1 Complex and method for producing epoxides by using the complex
02/06/2003WO2003010166A1 Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
02/06/2003WO2003010163A1 Novel compounds
02/06/2003WO2003010159A1 Piperidine derivatives as nmda receptor antagonists
02/06/2003WO2003010158A1 Novel compounds
02/06/2003WO2003010141A2 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure
02/06/2003WO2003010140A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure
02/06/2003WO2003009847A1 Substituted piperidines as modulators of the melanocortin receptor
02/06/2003WO2003000256A9 Substituted oxazolidinones for combinational therapy
02/06/2003WO2002079146A3 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
02/06/2003WO2002070516A3 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors
02/06/2003WO2002064586A3 Heterocyclic inhibitors of erk2 and uses thereof
02/06/2003WO2002059112A3 Pyrazole compounds useful as protein kinase inhibitors
02/06/2003WO2002048134A3 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists
02/06/2003WO2002046172A3 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
02/06/2003WO2002046141A3 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis
02/06/2003WO2002041843A3 Antiinflammation agents
02/06/2003WO2002010137A9 Indazole derivatives as jnk inhibitors
02/06/2003US20030028033 Which are used as herbicides, by forming a 2-(isoxazol-3-yl)-aniline compound of given formula and then halogenation, thioalkylation, oxidation and acylation; fewer steps, efficiency
02/06/2003US20030028022 Preferably tertiary amines comprising tetrahydroquinoline and benzimidazole; use treating human immunodeficiency virus (HIV) and Feline Immunodeficiency Virus (FIV)
02/06/2003US20030028018 Treating diseases characterized by activity of vascular endothelial growth factor receptor tyrosine kinases such as cancer
02/06/2003US20030027845 Ether derivatives useful as inhibitors of PDE4 isozymes
02/06/2003US20030027842 Halogenobenzimidazoles
02/06/2003US20030027836 Arylalkoxy-substituted tetrahydroisoquinoline-3-carboxylic acids or esters
02/06/2003US20030027825 Polymorphic form of a tachykinin receptor antagonist
02/06/2003US20030027821 Administering 2-oxy substituted benzoxazin-5-one derivative to a human or animal for the prevention or treatment of obesity or an obesity related disorder
02/06/2003US20030027798 For therapy
02/06/2003US20030027794 N-heterocyclic derivatives as NOS inhibitors
02/06/2003CA2454903A1 Substituted piperazines as modulators of the melanocortin receptor
02/06/2003CA2454702A1 Novel compounds
02/06/2003CA2452328A1 Substituted piperidines as modulators of the melanocortin receptor
02/05/2003EP1281709A1 Novel heterocyclic compounds with anti-inflammatory activity
02/05/2003EP1281702A2 Calcium receptor active molecules
02/05/2003EP1280798A1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them
02/05/2003EP1280797A1 Inhibitors of dipeptidyl peptidase iv
02/05/2003EP1280796A1 Pyrimidinyl methyl indole derivatives with antibacterial activity
02/05/2003EP1280793A2 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands
02/05/2003EP1280784A2 Biologically active 4h-benzo 1,4]oxazin-3-ones
02/05/2003EP1280783A2 Methods of treatment using benzoxazinones as peroxisome proliferator activated receptor gamma modulators
02/05/2003EP1280773A1 5-aryl-1.3.3.-trimethyl-2-methylene-indoline derivatives and salts thereof, methods for the production and use of said compounds for the temporary coloration of fibres
02/05/2003EP1117653B1 Quinoline and quinazoline derivatives and their use as inhibitors of cytokine mediated diseases
02/05/2003EP0984960B1 N-triazolyl-2-indolecarboxamides and their use as cck-a agonists
02/05/2003CN1395575A Novel piperidine compounds and drugs containing the same
02/05/2003CN1395566A Corticotropin releasing factor antagonists
02/05/2003CN1395562A Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
02/05/2003CN1394855A Substituted heterocyclic compound
02/05/2003CN1100884C Homogenous method for assay of double-stranded nucleic acids using flourescent dyes and kit useful therein
02/05/2003CN1100777C N-heterocyclic derivatives as NOS inhibitor
02/05/2003CN1100768C Substituted diphenyl oxazolines
02/05/2003CN1100761C Benzyloxy substituted aryl copounds and their use as fungicides and insecticides
02/04/2003US6515151 Method for the preparation of novel sidechain-bearing taxanes and intermediates thereof
02/04/2003US6515140 Psychological disorders; sleep disorders; anticonvulsants; cognition activators; drug abruse
02/04/2003US6515136 To the novel intermediates prepared by these methods. The biphenyl isoxazole sulfonamides prepared by the present methods are endothelin antagonists useful, inter alia, for the treatment of hypertension.
02/04/2003US6515135 Aminoaryl oxazolidinone N-oxides
02/04/2003US6515133 Certain diaryl imidazoles act as partial agonists or antagonists for NPY receptors, in particular NPY 5 receptors. They are of use, for example in treating loss of appetite. Such compounds bear aryl groups in the 2 position.
02/04/2003US6515027 Substituted benzanilides as CCR5 receptors ligands, antiinflammatory agents and antiviral agents
02/04/2003US6515002 Compounds and compositions for treating C1s-mediated diseases and conditions
02/04/2003US6514997 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
02/04/2003US6514996 Phosphodiesterase (PDE) IV inhibitors; used to treat inflammatory allergic diseases, autoimmune diseases, diseases of the central nervous system, insulin-resistant diabetes; wounds; AIDS, and the like.
02/04/2003US6514977 For treating p38 kinase mediated disorders
02/04/2003US6514974 Pyrido-, pyrimido-, pyridazo- and pyrazo- pyridazines having angiogenesis inhibiting activity
02/04/2003US6514971 Cinnoline derivatives and use as medicine
02/04/2003US6514633 Light emitting device material, light emitting device using thereof, and amine compound
02/04/2003CA2271566C Substituted phenyl pyrimidines useful in the treatment of cns disorders
01/2003
01/30/2003WO2003008411A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
01/30/2003WO2003008395A1 Substituted isoxazoles and the use thereof as antibiotics
01/30/2003WO2003008389A1 Oxazolidinone derivatives as potential antimicrobials
01/30/2003WO2003007959A1 Quinoxaline derivatives which have parp inhibitory action
01/30/2003WO2003007958A1 Tetrahydroquinoxalines acting as bradykinin antagonists
01/30/2003WO2003007942A1 Substituted isoindoles and the use thereof
01/30/2003WO2003007870A2 Oxazolidinone derivatives as antimicrobials
01/30/2003WO2002018376A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
01/30/2003WO2002018375A1 Quinazolines, medicaments, which contain these compounds and which are effective as tyrosine kinase inhibitors, their use, and methods for the production thereof
01/30/2003WO2002018351A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
01/30/2003WO2002012247A1 Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof
01/30/2003US20030023098 Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors
01/30/2003US20030023092 Reacting tetrahydrofuran compound with oxophilic electrophilic reagent to produce oxazoline compound